13/06/2026
Today, we are sharing our frequently asked questions (FAQs) regarding the announcement from UKHSA about the MenB vaccination programme. 🤔
We understand that there are many questions about the vaccine, who is eligible, and how individuals can receive it. Our goal is to help you feel well-informed.
We want to emphasise that we will continue to advocate for the MenB vaccine to be included in the NHS vaccination programme for teenagers and young adults. This will ensure that more young people are protected—not just this year, but indefinitely.
There's more information about the vaccine programme on our website. Click on the link to read more. 🔗 https://bit.ly/3XyOa3b
[Image descriptions: Image 1 - Orange background with text: "We're here to help. Here are some FAQs about yesterday's MenB vaccine programme announcement."
Image 2 - The image contains a text announcement on a patterned orange background. The header reads, "What has been announced?" The text details that the UK Health Security Agency has launched a one-time meningococcal B vaccination programme targeting young individuals before starting university or further education. It aims to begin before the 2026 academic year to reduce the risk of the disease.
Image 3 - The image contains text reading "Who is eligible for the MenB vaccination programme?" It states that the programme is offered to students in England and Wales born between September 1, 2007, and August 31, 2008, equivalent final-year students in Scotland and Northern Ireland, individuals under 25 attending university for the first time in Autumn 2026, and international students from the UK and Crown Dependencies. The background is orange with a subtle pattern.
Image 4 - The image is an informational poster from Meningitis Now. It explains that eligible individuals require two doses of the MenB vaccine for optimal protection. The first dose is available from July 2026 and the second dose from August 2026. The second dose needs to be taken at least 28 days after the first, with an additional two weeks needed for immunity to build. The process takes around six weeks from start to finish, emphasising the importance of starting early before the autumn term.
Image 5 - Orange flyer with white and blue text. The title reads, "What happens now to the 'No Plan B for MenB' campaign?" The text discusses the positive impact of the programme in protecting young people from MenB and emphasises the importance of including it in the NHS vaccination programme to ensure ongoing protection.
Image 6 - The image contains text on an orange background, providing information about finding more details on the meningitis vaccination programme. It mentions that updates will be available from the NHS, public health agencies, and Meningitis Now. Additional information on symptoms, after-effects, support services, and awareness campaigns is accessible on the Meningitis Now website. A helpline is available at specified hours via phone and email for further inquiries.]